nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Metastatic neoplasm—Temozolomide—malignant glioma	0.0206	0.0503	CcSEcCtD
Gemcitabine—Disease progression—Carmustine—malignant glioma	0.0187	0.0457	CcSEcCtD
Gemcitabine—Pulmonary toxicity—Carmustine—malignant glioma	0.018	0.0439	CcSEcCtD
Gemcitabine—Pulmonary fibrosis—Carmustine—malignant glioma	0.00928	0.0227	CcSEcCtD
Gemcitabine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00897	0.0219	CcSEcCtD
Gemcitabine—Lung infiltration—Carmustine—malignant glioma	0.00871	0.0213	CcSEcCtD
Gemcitabine—POLE—embryo—malignant glioma	0.00861	0.0422	CbGeAlD
Gemcitabine—CMPK1—brainstem—malignant glioma	0.00842	0.0413	CbGeAlD
Gemcitabine—Interstitial pneumonia—Temozolomide—malignant glioma	0.00816	0.0199	CcSEcCtD
Gemcitabine—Lymphopenia—Temozolomide—malignant glioma	0.00771	0.0188	CcSEcCtD
Gemcitabine—CMPK1—telencephalon—malignant glioma	0.00747	0.0366	CbGeAlD
Gemcitabine—Nephropathy toxic—Carmustine—malignant glioma	0.00711	0.0174	CcSEcCtD
Gemcitabine—RRM2—embryo—malignant glioma	0.00709	0.0348	CbGeAlD
Gemcitabine—Febrile neutropenia—Carmustine—malignant glioma	0.00679	0.0166	CcSEcCtD
Gemcitabine—Transaminases increased—Carmustine—malignant glioma	0.00671	0.0164	CcSEcCtD
Gemcitabine—Febrile neutropenia—Temozolomide—malignant glioma	0.00656	0.016	CcSEcCtD
Gemcitabine—POLA1—retina—malignant glioma	0.00656	0.0322	CbGeAlD
Gemcitabine—Interstitial lung disease—Carmustine—malignant glioma	0.00577	0.0141	CcSEcCtD
Gemcitabine—Interstitial lung disease—Temozolomide—malignant glioma	0.00557	0.0136	CcSEcCtD
Gemcitabine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00552	0.0135	CcSEcCtD
Gemcitabine—CMPK1—midbrain—malignant glioma	0.00536	0.0263	CbGeAlD
Gemcitabine—Hepatotoxicity—Carmustine—malignant glioma	0.00529	0.0129	CcSEcCtD
Gemcitabine—CMPK1—spinal cord—malignant glioma	0.00523	0.0257	CbGeAlD
Gemcitabine—RRM1—retina—malignant glioma	0.00521	0.0255	CbGeAlD
Gemcitabine—POLD1—cerebellum—malignant glioma	0.0052	0.0255	CbGeAlD
Gemcitabine—Hepatotoxicity—Temozolomide—malignant glioma	0.00511	0.0125	CcSEcCtD
Gemcitabine—Petechiae—Temozolomide—malignant glioma	0.0048	0.0117	CcSEcCtD
Gemcitabine—RRM1—telencephalon—malignant glioma	0.00479	0.0235	CbGeAlD
Gemcitabine—Extravasation—Carmustine—malignant glioma	0.00468	0.0114	CcSEcCtD
Gemcitabine—DCK—embryo—malignant glioma	0.00457	0.0224	CbGeAlD
Gemcitabine—Drug interaction—Carmustine—malignant glioma	0.0044	0.0108	CcSEcCtD
Gemcitabine—SLC29A2—cerebellum—malignant glioma	0.00436	0.0214	CbGeAlD
Gemcitabine—TYMS—telencephalon—malignant glioma	0.00434	0.0213	CbGeAlD
Gemcitabine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00434	0.0106	CcSEcCtD
Gemcitabine—CMPK1—central nervous system—malignant glioma	0.00425	0.0208	CbGeAlD
Gemcitabine—POLD1—brain—malignant glioma	0.00422	0.0207	CbGeAlD
Gemcitabine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00417	0.0102	CcSEcCtD
Gemcitabine—CMPK1—cerebellum—malignant glioma	0.00415	0.0204	CbGeAlD
Gemcitabine—Hearing impaired—Temozolomide—malignant glioma	0.00414	0.0101	CcSEcCtD
Gemcitabine—Injection site reaction—Carmustine—malignant glioma	0.00406	0.00992	CcSEcCtD
Gemcitabine—DCK—retina—malignant glioma	0.00404	0.0198	CbGeAlD
Gemcitabine—Respiratory failure—Temozolomide—malignant glioma	0.00402	0.00982	CcSEcCtD
Gemcitabine—POLE—central nervous system—malignant glioma	0.00398	0.0195	CbGeAlD
Gemcitabine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00395	0.00964	CcSEcCtD
Gemcitabine—Skin exfoliation—Carmustine—malignant glioma	0.0039	0.00952	CcSEcCtD
Gemcitabine—SLC29A1—telencephalon—malignant glioma	0.00389	0.0191	CbGeAlD
Gemcitabine—POLE—cerebellum—malignant glioma	0.00389	0.0191	CbGeAlD
Gemcitabine—Neuropathy—Carmustine—malignant glioma	0.00383	0.00937	CcSEcCtD
Gemcitabine—Influenza like illness—Temozolomide—malignant glioma	0.00383	0.00936	CcSEcCtD
Gemcitabine—Skin exfoliation—Temozolomide—malignant glioma	0.00377	0.0092	CcSEcCtD
Gemcitabine—RRM1—medulla oblongata—malignant glioma	0.00376	0.0185	CbGeAlD
Gemcitabine—DCK—telencephalon—malignant glioma	0.00372	0.0182	CbGeAlD
Gemcitabine—Neuropathy—Temozolomide—malignant glioma	0.0037	0.00905	CcSEcCtD
Gemcitabine—SLC29A2—brain—malignant glioma	0.00354	0.0174	CbGeAlD
Gemcitabine—ABCC10—telencephalon—malignant glioma	0.00354	0.0174	CbGeAlD
Gemcitabine—Sepsis—Carmustine—malignant glioma	0.00354	0.00866	CcSEcCtD
Gemcitabine—RRM1—midbrain—malignant glioma	0.00344	0.0169	CbGeAlD
Gemcitabine—CMPK1—brain—malignant glioma	0.00337	0.0165	CbGeAlD
Gemcitabine—RRM1—spinal cord—malignant glioma	0.00335	0.0165	CbGeAlD
Gemcitabine—POLA1—cerebellum—malignant glioma	0.00335	0.0164	CbGeAlD
Gemcitabine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00329	0.00805	CcSEcCtD
Gemcitabine—RRM2—central nervous system—malignant glioma	0.00328	0.0161	CbGeAlD
Gemcitabine—Deafness—Temozolomide—malignant glioma	0.0032	0.00782	CcSEcCtD
Gemcitabine—Hepatic failure—Temozolomide—malignant glioma	0.00319	0.00779	CcSEcCtD
Gemcitabine—POLE—brain—malignant glioma	0.00316	0.0155	CbGeAlD
Gemcitabine—TYMS—midbrain—malignant glioma	0.00312	0.0153	CbGeAlD
Gemcitabine—DCK—medulla oblongata—malignant glioma	0.00292	0.0143	CbGeAlD
Gemcitabine—Face oedema—Carmustine—malignant glioma	0.00286	0.00699	CcSEcCtD
Gemcitabine—ABCC10—medulla oblongata—malignant glioma	0.00278	0.0137	CbGeAlD
Gemcitabine—Face oedema—Temozolomide—malignant glioma	0.00276	0.00676	CcSEcCtD
Gemcitabine—Liver function test abnormal—Carmustine—malignant glioma	0.00274	0.00669	CcSEcCtD
Gemcitabine—POLA1—brain—malignant glioma	0.00272	0.0133	CbGeAlD
Gemcitabine—RRM1—central nervous system—malignant glioma	0.00272	0.0133	CbGeAlD
Gemcitabine—Hypokalaemia—Carmustine—malignant glioma	0.0027	0.00659	CcSEcCtD
Gemcitabine—DCK—midbrain—malignant glioma	0.00267	0.0131	CbGeAlD
Gemcitabine—RRM1—cerebellum—malignant glioma	0.00266	0.013	CbGeAlD
Gemcitabine—Hypokalaemia—Temozolomide—malignant glioma	0.00261	0.00637	CcSEcCtD
Gemcitabine—DCK—spinal cord—malignant glioma	0.00261	0.0128	CbGeAlD
Gemcitabine—RRM2—brain—malignant glioma	0.0026	0.0128	CbGeAlD
Gemcitabine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00258	0.0063	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00258	0.0063	CcSEcCtD
Gemcitabine—ABCC10—midbrain—malignant glioma	0.00254	0.0125	CbGeAlD
Gemcitabine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00253	0.00617	CcSEcCtD
Gemcitabine—ABCC10—spinal cord—malignant glioma	0.00248	0.0122	CbGeAlD
Gemcitabine—TYMS—central nervous system—malignant glioma	0.00247	0.0121	CbGeAlD
Gemcitabine—Pancytopenia—Carmustine—malignant glioma	0.00243	0.00594	CcSEcCtD
Gemcitabine—TYMS—cerebellum—malignant glioma	0.00241	0.0118	CbGeAlD
Gemcitabine—Neutropenia—Carmustine—malignant glioma	0.0024	0.00585	CcSEcCtD
Gemcitabine—Pancytopenia—Temozolomide—malignant glioma	0.00235	0.00574	CcSEcCtD
Gemcitabine—Neutropenia—Temozolomide—malignant glioma	0.00231	0.00566	CcSEcCtD
Gemcitabine—Hyperglycaemia—Carmustine—malignant glioma	0.00231	0.00565	CcSEcCtD
Gemcitabine—Pneumonia—Carmustine—malignant glioma	0.0023	0.00561	CcSEcCtD
Gemcitabine—Renal failure—Carmustine—malignant glioma	0.00224	0.00549	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Carmustine—malignant glioma	0.00224	0.00547	CcSEcCtD
Gemcitabine—Hyperglycaemia—Temozolomide—malignant glioma	0.00223	0.00546	CcSEcCtD
Gemcitabine—Stomatitis—Carmustine—malignant glioma	0.00223	0.00544	CcSEcCtD
Gemcitabine—Pneumonia—Temozolomide—malignant glioma	0.00222	0.00542	CcSEcCtD
Gemcitabine—SLC29A1—central nervous system—malignant glioma	0.00221	0.0109	CbGeAlD
Gemcitabine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00219	0.00535	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00216	0.00529	CcSEcCtD
Gemcitabine—SLC29A1—cerebellum—malignant glioma	0.00216	0.0106	CbGeAlD
Gemcitabine—RRM1—brain—malignant glioma	0.00216	0.0106	CbGeAlD
Gemcitabine—Stomatitis—Temozolomide—malignant glioma	0.00215	0.00526	CcSEcCtD
Gemcitabine—DCK—central nervous system—malignant glioma	0.00211	0.0104	CbGeAlD
Gemcitabine—ABCB1—blood vessel—malignant glioma	0.00211	0.0103	CbGeAlD
Gemcitabine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00209	0.0051	CcSEcCtD
Gemcitabine—DCK—cerebellum—malignant glioma	0.00207	0.0101	CbGeAlD
Gemcitabine—Haemoglobin—Carmustine—malignant glioma	0.00206	0.00504	CcSEcCtD
Gemcitabine—Haemorrhage—Carmustine—malignant glioma	0.00205	0.00501	CcSEcCtD
Gemcitabine—Oedema peripheral—Carmustine—malignant glioma	0.00202	0.00494	CcSEcCtD
Gemcitabine—Connective tissue disorder—Carmustine—malignant glioma	0.00201	0.00492	CcSEcCtD
Gemcitabine—Haemoglobin—Temozolomide—malignant glioma	0.00199	0.00487	CcSEcCtD
Gemcitabine—Haemorrhage—Temozolomide—malignant glioma	0.00198	0.00484	CcSEcCtD
Gemcitabine—ABCC10—cerebellum—malignant glioma	0.00197	0.00965	CbGeAlD
Gemcitabine—Pharyngitis—Temozolomide—malignant glioma	0.00197	0.00481	CcSEcCtD
Gemcitabine—TYMS—brain—malignant glioma	0.00196	0.00961	CbGeAlD
Gemcitabine—Urinary tract disorder—Temozolomide—malignant glioma	0.00196	0.00478	CcSEcCtD
Gemcitabine—Oedema peripheral—Temozolomide—malignant glioma	0.00195	0.00477	CcSEcCtD
Gemcitabine—Connective tissue disorder—Temozolomide—malignant glioma	0.00195	0.00476	CcSEcCtD
Gemcitabine—Urethral disorder—Temozolomide—malignant glioma	0.00194	0.00475	CcSEcCtD
Gemcitabine—Erythema multiforme—Temozolomide—malignant glioma	0.00187	0.00458	CcSEcCtD
Gemcitabine—Cardiac disorder—Temozolomide—malignant glioma	0.00184	0.00449	CcSEcCtD
Gemcitabine—Arrhythmia—Carmustine—malignant glioma	0.00183	0.00448	CcSEcCtD
Gemcitabine—Alopecia—Carmustine—malignant glioma	0.00181	0.00443	CcSEcCtD
Gemcitabine—Angiopathy—Temozolomide—malignant glioma	0.0018	0.00439	CcSEcCtD
Gemcitabine—Immune system disorder—Temozolomide—malignant glioma	0.00179	0.00437	CcSEcCtD
Gemcitabine—Mediastinal disorder—Temozolomide—malignant glioma	0.00179	0.00436	CcSEcCtD
Gemcitabine—Erythema—Carmustine—malignant glioma	0.00178	0.00436	CcSEcCtD
Gemcitabine—Chills—Temozolomide—malignant glioma	0.00178	0.00434	CcSEcCtD
Gemcitabine—SLC29A1—brain—malignant glioma	0.00176	0.00862	CbGeAlD
Gemcitabine—Alopecia—Temozolomide—malignant glioma	0.00175	0.00428	CcSEcCtD
Gemcitabine—Back pain—Carmustine—malignant glioma	0.00173	0.00422	CcSEcCtD
Gemcitabine—Erythema—Temozolomide—malignant glioma	0.00172	0.00421	CcSEcCtD
Gemcitabine—DCK—brain—malignant glioma	0.00168	0.00823	CbGeAlD
Gemcitabine—Back pain—Temozolomide—malignant glioma	0.00167	0.00408	CcSEcCtD
Gemcitabine—Anaemia—Carmustine—malignant glioma	0.00165	0.00403	CcSEcCtD
Gemcitabine—Ill-defined disorder—Temozolomide—malignant glioma	0.0016	0.00391	CcSEcCtD
Gemcitabine—ABCC10—brain—malignant glioma	0.0016	0.00784	CbGeAlD
Gemcitabine—Leukopenia—Carmustine—malignant glioma	0.0016	0.0039	CcSEcCtD
Gemcitabine—Anaemia—Temozolomide—malignant glioma	0.00159	0.0039	CcSEcCtD
Gemcitabine—Malaise—Temozolomide—malignant glioma	0.00156	0.0038	CcSEcCtD
Gemcitabine—Leukopenia—Temozolomide—malignant glioma	0.00154	0.00377	CcSEcCtD
Gemcitabine—Hypertension—Carmustine—malignant glioma	0.00154	0.00377	CcSEcCtD
Gemcitabine—Myalgia—Carmustine—malignant glioma	0.00152	0.00371	CcSEcCtD
Gemcitabine—Chest pain—Carmustine—malignant glioma	0.00152	0.00371	CcSEcCtD
Gemcitabine—Cough—Temozolomide—malignant glioma	0.00151	0.00368	CcSEcCtD
Gemcitabine—Hypertension—Temozolomide—malignant glioma	0.00149	0.00364	CcSEcCtD
Gemcitabine—Myalgia—Temozolomide—malignant glioma	0.00147	0.00359	CcSEcCtD
Gemcitabine—Arthralgia—Temozolomide—malignant glioma	0.00147	0.00359	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00146	0.00356	CcSEcCtD
Gemcitabine—Oedema—Carmustine—malignant glioma	0.00146	0.00356	CcSEcCtD
Gemcitabine—Discomfort—Temozolomide—malignant glioma	0.00145	0.00355	CcSEcCtD
Gemcitabine—Infection—Carmustine—malignant glioma	0.00145	0.00354	CcSEcCtD
Gemcitabine—Thrombocytopenia—Carmustine—malignant glioma	0.00143	0.00348	CcSEcCtD
Gemcitabine—Anaphylactic shock—Temozolomide—malignant glioma	0.00141	0.00344	CcSEcCtD
Gemcitabine—Oedema—Temozolomide—malignant glioma	0.00141	0.00344	CcSEcCtD
Gemcitabine—Infection—Temozolomide—malignant glioma	0.0014	0.00342	CcSEcCtD
Gemcitabine—Anorexia—Carmustine—malignant glioma	0.00139	0.00339	CcSEcCtD
Gemcitabine—Nervous system disorder—Temozolomide—malignant glioma	0.00138	0.00337	CcSEcCtD
Gemcitabine—Thrombocytopenia—Temozolomide—malignant glioma	0.00138	0.00337	CcSEcCtD
Gemcitabine—Skin disorder—Temozolomide—malignant glioma	0.00137	0.00334	CcSEcCtD
Gemcitabine—Hypotension—Carmustine—malignant glioma	0.00136	0.00333	CcSEcCtD
Gemcitabine—Hyperhidrosis—Temozolomide—malignant glioma	0.00136	0.00333	CcSEcCtD
Gemcitabine—Anorexia—Temozolomide—malignant glioma	0.00134	0.00328	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00133	0.00324	CcSEcCtD
Gemcitabine—Insomnia—Carmustine—malignant glioma	0.00132	0.00322	CcSEcCtD
Gemcitabine—Paraesthesia—Carmustine—malignant glioma	0.00131	0.0032	CcSEcCtD
Gemcitabine—Dyspnoea—Carmustine—malignant glioma	0.0013	0.00317	CcSEcCtD
Gemcitabine—Somnolence—Carmustine—malignant glioma	0.00129	0.00316	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00128	0.00313	CcSEcCtD
Gemcitabine—Insomnia—Temozolomide—malignant glioma	0.00127	0.00311	CcSEcCtD
Gemcitabine—Decreased appetite—Carmustine—malignant glioma	0.00127	0.00309	CcSEcCtD
Gemcitabine—Paraesthesia—Temozolomide—malignant glioma	0.00126	0.00309	CcSEcCtD
Gemcitabine—ABCB1—embryo—malignant glioma	0.00126	0.00617	CbGeAlD
Gemcitabine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00126	0.00307	CcSEcCtD
Gemcitabine—Dyspnoea—Temozolomide—malignant glioma	0.00125	0.00307	CcSEcCtD
Gemcitabine—Somnolence—Temozolomide—malignant glioma	0.00125	0.00306	CcSEcCtD
Gemcitabine—Pain—Carmustine—malignant glioma	0.00125	0.00304	CcSEcCtD
Gemcitabine—Constipation—Carmustine—malignant glioma	0.00125	0.00304	CcSEcCtD
Gemcitabine—Decreased appetite—Temozolomide—malignant glioma	0.00122	0.00299	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00122	0.00297	CcSEcCtD
Gemcitabine—Fatigue—Temozolomide—malignant glioma	0.00121	0.00297	CcSEcCtD
Gemcitabine—Pain—Temozolomide—malignant glioma	0.0012	0.00294	CcSEcCtD
Gemcitabine—Constipation—Temozolomide—malignant glioma	0.0012	0.00294	CcSEcCtD
Gemcitabine—Feeling abnormal—Carmustine—malignant glioma	0.0012	0.00293	CcSEcCtD
Gemcitabine—Feeling abnormal—Temozolomide—malignant glioma	0.00116	0.00283	CcSEcCtD
Gemcitabine—Body temperature increased—Carmustine—malignant glioma	0.00115	0.00281	CcSEcCtD
Gemcitabine—Body temperature increased—Temozolomide—malignant glioma	0.00111	0.00272	CcSEcCtD
Gemcitabine—ABCB1—retina—malignant glioma	0.00111	0.00545	CbGeAlD
Gemcitabine—Asthenia—Carmustine—malignant glioma	0.00105	0.00255	CcSEcCtD
Gemcitabine—ABCB1—telencephalon—malignant glioma	0.00102	0.00502	CbGeAlD
Gemcitabine—Asthenia—Temozolomide—malignant glioma	0.00101	0.00247	CcSEcCtD
Gemcitabine—Diarrhoea—Carmustine—malignant glioma	0.000997	0.00244	CcSEcCtD
Gemcitabine—Pruritus—Temozolomide—malignant glioma	0.000996	0.00243	CcSEcCtD
Gemcitabine—Diarrhoea—Temozolomide—malignant glioma	0.000963	0.00235	CcSEcCtD
Gemcitabine—Vomiting—Carmustine—malignant glioma	0.000926	0.00226	CcSEcCtD
Gemcitabine—Rash—Carmustine—malignant glioma	0.000918	0.00224	CcSEcCtD
Gemcitabine—Dermatitis—Carmustine—malignant glioma	0.000918	0.00224	CcSEcCtD
Gemcitabine—Headache—Carmustine—malignant glioma	0.000912	0.00223	CcSEcCtD
Gemcitabine—Vomiting—Temozolomide—malignant glioma	0.000895	0.00219	CcSEcCtD
Gemcitabine—Rash—Temozolomide—malignant glioma	0.000888	0.00217	CcSEcCtD
Gemcitabine—Dermatitis—Temozolomide—malignant glioma	0.000887	0.00217	CcSEcCtD
Gemcitabine—Headache—Temozolomide—malignant glioma	0.000882	0.00215	CcSEcCtD
Gemcitabine—Nausea—Carmustine—malignant glioma	0.000865	0.00211	CcSEcCtD
Gemcitabine—Nausea—Temozolomide—malignant glioma	0.000836	0.00204	CcSEcCtD
Gemcitabine—ABCB1—medulla oblongata—malignant glioma	0.000804	0.00394	CbGeAlD
Gemcitabine—ABCB1—midbrain—malignant glioma	0.000735	0.0036	CbGeAlD
Gemcitabine—ABCB1—spinal cord—malignant glioma	0.000717	0.00352	CbGeAlD
Gemcitabine—ABCB1—central nervous system—malignant glioma	0.000582	0.00285	CbGeAlD
Gemcitabine—ABCB1—cerebellum—malignant glioma	0.000568	0.00279	CbGeAlD
Gemcitabine—ABCB1—brain—malignant glioma	0.000462	0.00226	CbGeAlD
Gemcitabine—RRM2—Metabolism—CYP2C18—malignant glioma	0.000208	0.000538	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BCAN—malignant glioma	0.000208	0.000536	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2C18—malignant glioma	0.000207	0.000535	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CG—malignant glioma	0.000206	0.000534	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000206	0.000533	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—IDH1—malignant glioma	0.000205	0.00053	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTT1—malignant glioma	0.000204	0.000528	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000204	0.000527	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000201	0.00052	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PPARG—malignant glioma	0.000199	0.000515	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000199	0.000514	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SPHK1—malignant glioma	0.000198	0.000513	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000198	0.000513	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000198	0.000511	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2C18—malignant glioma	0.000194	0.000503	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000194	0.000501	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000193	0.000498	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS1—malignant glioma	0.000192	0.000495	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000187	0.000485	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTP1—malignant glioma	0.000187	0.000483	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000187	0.000483	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000186	0.00048	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CAT—malignant glioma	0.000182	0.00047	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BRCA2—malignant glioma	0.000182	0.000469	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CD—malignant glioma	0.000181	0.000469	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2B—malignant glioma	0.00018	0.000465	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—malignant glioma	0.000178	0.000461	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—BCHE—malignant glioma	0.000178	0.00046	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SLC5A5—malignant glioma	0.000176	0.000455	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000176	0.000454	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000175	0.000453	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BRCA2—malignant glioma	0.000174	0.00045	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000174	0.000449	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2B—malignant glioma	0.000172	0.000446	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NCOR1—malignant glioma	0.000172	0.000444	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000171	0.000443	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000171	0.000442	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTT1—malignant glioma	0.000168	0.000435	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000168	0.000435	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000168	0.000434	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—malignant glioma	0.000167	0.000432	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—IDH2—malignant glioma	0.000167	0.000432	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000167	0.000432	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000166	0.00043	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000162	0.000417	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000161	0.000416	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CB—malignant glioma	0.000158	0.000409	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS1—malignant glioma	0.000158	0.000408	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000158	0.000407	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—malignant glioma	0.000157	0.000407	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2B6—malignant glioma	0.000157	0.000407	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS1—malignant glioma	0.000157	0.000405	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—malignant glioma	0.000157	0.000405	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000156	0.000404	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BIRC5—malignant glioma	0.000155	0.000401	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000154	0.000399	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000151	0.00039	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—malignant glioma	0.00015	0.000389	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—malignant glioma	0.00015	0.000389	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00015	0.000388	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—malignant glioma	0.00015	0.000386	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000149	0.000385	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BIRC5—malignant glioma	0.000149	0.000385	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000148	0.000383	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS1—malignant glioma	0.000147	0.000381	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—BCHE—malignant glioma	0.000147	0.000379	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MDM2—malignant glioma	0.000146	0.000377	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—BCHE—malignant glioma	0.000146	0.000377	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MDM2—malignant glioma	0.000145	0.000375	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SLC5A5—malignant glioma	0.000145	0.000374	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—malignant glioma	0.000144	0.000373	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—malignant glioma	0.000144	0.000372	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC5A5—malignant glioma	0.000144	0.000372	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—IDH1—malignant glioma	0.000144	0.000372	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000144	0.000372	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000143	0.000369	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—malignant glioma	0.000142	0.000366	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000141	0.000366	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MDM2—malignant glioma	0.00014	0.000362	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CAV1—malignant glioma	0.00014	0.000362	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RTEL1—malignant glioma	0.000139	0.00036	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SPHK1—malignant glioma	0.000139	0.00036	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000139	0.000359	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CAT—malignant glioma	0.000138	0.000356	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—BCHE—malignant glioma	0.000137	0.000354	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000137	0.000353	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000137	0.000353	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—malignant glioma	0.000137	0.000353	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2C18—malignant glioma	0.000136	0.000352	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC5A5—malignant glioma	0.000135	0.00035	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000133	0.000345	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000133	0.000344	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000132	0.000342	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000131	0.000339	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NCOR1—malignant glioma	0.00013	0.000336	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000129	0.000334	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—malignant glioma	0.000128	0.00033	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000127	0.000328	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000124	0.00032	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000124	0.00032	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000124	0.000319	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000123	0.000319	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—malignant glioma	0.000123	0.000318	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000123	0.000318	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000122	0.000315	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000121	0.000313	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—malignant glioma	0.000117	0.000302	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—malignant glioma	0.000116	0.0003	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000115	0.000297	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—malignant glioma	0.000114	0.000295	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAT—malignant glioma	0.000114	0.000293	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—malignant glioma	0.000113	0.000293	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAT—malignant glioma	0.000113	0.000292	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CD—malignant glioma	0.000112	0.00029	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000112	0.000289	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000112	0.000289	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—malignant glioma	0.00011	0.000285	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.00011	0.000285	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—malignant glioma	0.000109	0.000283	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—malignant glioma	0.000109	0.000282	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NCOR1—malignant glioma	0.000107	0.000277	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000107	0.000277	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NCOR1—malignant glioma	0.000107	0.000275	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CAV1—malignant glioma	0.000106	0.000274	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAT—malignant glioma	0.000106	0.000274	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000105	0.000271	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS1—malignant glioma	0.000103	0.000267	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—malignant glioma	0.000103	0.000266	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—malignant glioma	0.000102	0.000264	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—malignant glioma	0.000101	0.000262	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NCOR1—malignant glioma	0.0001	0.000259	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MDM2—malignant glioma	9.98e-05	0.000258	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	9.97e-05	0.000258	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—malignant glioma	9.86e-05	0.000255	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—malignant glioma	9.79e-05	0.000253	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CB—malignant glioma	9.77e-05	0.000253	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—malignant glioma	9.68e-05	0.00025	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—malignant glioma	9.67e-05	0.00025	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—malignant glioma	9.64e-05	0.000249	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BCHE—malignant glioma	9.61e-05	0.000248	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—malignant glioma	9.56e-05	0.000247	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—malignant glioma	9.49e-05	0.000245	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—malignant glioma	9.33e-05	0.000241	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—malignant glioma	8.99e-05	0.000232	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	8.94e-05	0.000231	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAV1—malignant glioma	8.74e-05	0.000226	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAV1—malignant glioma	8.69e-05	0.000225	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	8.65e-05	0.000224	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	8.55e-05	0.000221	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—malignant glioma	8.5e-05	0.00022	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—malignant glioma	8.45e-05	0.000218	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—malignant glioma	8.37e-05	0.000216	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—malignant glioma	8.32e-05	0.000215	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAV1—malignant glioma	8.17e-05	0.000211	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—malignant glioma	8.04e-05	0.000208	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—COX8A—malignant glioma	8.01e-05	0.000207	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—malignant glioma	7.96e-05	0.000206	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—malignant glioma	7.91e-05	0.000205	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—malignant glioma	7.88e-05	0.000204	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—malignant glioma	7.8e-05	0.000202	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	7.73e-05	0.0002	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—malignant glioma	7.68e-05	0.000199	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—malignant glioma	7.64e-05	0.000198	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—malignant glioma	7.64e-05	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	7.47e-05	0.000193	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—malignant glioma	7.44e-05	0.000192	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAT—malignant glioma	7.44e-05	0.000192	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—malignant glioma	7.41e-05	0.000191	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—malignant glioma	7.34e-05	0.00019	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	7.28e-05	0.000188	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—malignant glioma	7.18e-05	0.000186	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NCOR1—malignant glioma	7.02e-05	0.000182	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—malignant glioma	7e-05	0.000181	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—malignant glioma	6.97e-05	0.00018	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—malignant glioma	6.95e-05	0.00018	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.92e-05	0.000179	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.82e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ASMT—malignant glioma	6.81e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.81e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.79e-05	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.72e-05	0.000174	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—malignant glioma	6.68e-05	0.000173	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	6.57e-05	0.00017	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—malignant glioma	6.54e-05	0.000169	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BCAN—malignant glioma	6.4e-05	0.000166	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—malignant glioma	6.4e-05	0.000165	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.25e-05	0.000162	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.1e-05	0.000158	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—malignant glioma	6.1e-05	0.000158	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—malignant glioma	6.06e-05	0.000157	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—malignant glioma	6.04e-05	0.000156	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—malignant glioma	6.01e-05	0.000155	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—malignant glioma	5.96e-05	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.95e-05	0.000154	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.73e-05	0.000148	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—malignant glioma	5.73e-05	0.000148	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAV1—malignant glioma	5.73e-05	0.000148	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—malignant glioma	5.7e-05	0.000147	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—malignant glioma	5.65e-05	0.000146	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—malignant glioma	5.49e-05	0.000142	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—malignant glioma	5.27e-05	0.000136	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—malignant glioma	5.24e-05	0.000135	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—malignant glioma	5.22e-05	0.000135	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.18e-05	0.000134	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—IDH2—malignant glioma	5.16e-05	0.000133	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—malignant glioma	5.03e-05	0.00013	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—malignant glioma	4.93e-05	0.000127	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—malignant glioma	4.87e-05	0.000126	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2B6—malignant glioma	4.85e-05	0.000125	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.76e-05	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.66e-05	0.00012	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—malignant glioma	4.59e-05	0.000119	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—malignant glioma	4.52e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—IDH1—malignant glioma	4.44e-05	0.000115	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.44e-05	0.000115	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.4e-05	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SPHK1—malignant glioma	4.29e-05	0.000111	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2C18—malignant glioma	4.21e-05	0.000109	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.04e-05	0.000104	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—malignant glioma	4e-05	0.000103	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—malignant glioma	3.96e-05	0.000102	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.91e-05	0.000101	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—malignant glioma	3.72e-05	9.61e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—malignant glioma	3.7e-05	9.55e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—malignant glioma	3.69e-05	9.53e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—malignant glioma	3.47e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—malignant glioma	3.45e-05	8.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—malignant glioma	3.4e-05	8.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.3e-05	8.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS1—malignant glioma	3.19e-05	8.24e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—malignant glioma	3.04e-05	7.85e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—malignant glioma	3.02e-05	7.8e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BCHE—malignant glioma	2.96e-05	7.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—malignant glioma	2.93e-05	7.57e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—malignant glioma	2.84e-05	7.34e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.7e-05	6.97e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—malignant glioma	2.44e-05	6.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—malignant glioma	2.36e-05	6.1e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAT—malignant glioma	2.3e-05	5.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOR1—malignant glioma	2.17e-05	5.6e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—malignant glioma	1.99e-05	5.14e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAV1—malignant glioma	1.77e-05	4.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—malignant glioma	1.61e-05	4.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—malignant glioma	1.55e-05	4.02e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—malignant glioma	1.41e-05	3.66e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—malignant glioma	1.23e-05	3.19e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—malignant glioma	1.22e-05	3.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—malignant glioma	1.07e-05	2.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—malignant glioma	7.52e-06	1.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—malignant glioma	6.14e-06	1.59e-05	CbGpPWpGaD
